Read More Pharma Industry News Merck to acquire Imago BioSciences to expand blood disorder drugs portfolio Pharma giant Merck will acquire Imago BioSciences, a Nasdaq-listed clinical stage biopharmaceutical company, for a price of $36… byRaghuram KadariNovember 23, 2022